secwatch.observer — SEC 8-K summary
======================================

Issuer:     CAPRICOR THERAPEUTICS, INC. (CAPR)
CIK:        0001133869
Form:       8-K
Filed at:   2024-10-17T23:59:59+00:00
Accession:  0001558370-24-013357
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Capricor Therapeutics prices ~$75M public offering of 4.4M shares at $17/sh
---------------------------------------------------------------------------

- Gross proceeds ~$75M from 4,412,000 shares at $17.00/sh; underwriters have 30-day option for up to 661,800 additional shares.
- Offering expected to close October 18, 2024; Piper Sandler and Oppenheimer act as joint book-running managers.
- Net proceeds to fund continued product candidate development, manufacturing, working capital, and general corporate purposes.
- Offering made under effective Form S-3 shelf registration; prospectus supplement filed October 16, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133869/000155837024013357/0001558370-24-013357-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133869/000155837024013357/capr-20241016x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-013357

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer